MGMT Promoter Methylation and Parathyroid Carcinoma

Show full item record



Permalink

http://hdl.handle.net/10138/306780

Citation

Storvall , S , Ryhänen , E , Heiskanen , I , Vesterinen , T , Bensch , F V , Schildt , J , Kytölä , S , Karhu , A , Arola , J & Schalin-Jäntti , C 2019 , ' MGMT Promoter Methylation and Parathyroid Carcinoma ' , Journal of the Endocrine Society , vol. 3 , no. 11 , pp. 2114–2122 . https://doi.org/10.1210/js.2019-00175

Title: MGMT Promoter Methylation and Parathyroid Carcinoma
Author: Storvall, Sara; Ryhänen, Eeva; Heiskanen, Ilkka; Vesterinen, Tiina; Bensch, Frank V.; Schildt, Jukka; Kytölä, Soili; Karhu, Auli; Arola, Johanna; Schalin-Jäntti, Camilla
Contributor organization: Endokrinologian yksikkö
HUS Abdominal Center
University of Helsinki
Department of Medicine
II kirurgian klinikka
HUSLAB
Department of Pathology
HUS Medical Imaging Center
Clinicum
Department of Diagnostics and Therapeutics
University Management
Genome-Scale Biology (GSB) Research Program
Department of Medical and Clinical Genetics
Lauri Antti Aaltonen / Principal Investigator
ATG - Applied Tumor Genomics
Research Programs Unit
Date: 2019-11
Language: eng
Number of pages: 9
Belongs to series: Journal of the Endocrine Society
ISSN: 2472-1972
DOI: https://doi.org/10.1210/js.2019-00175
URI: http://hdl.handle.net/10138/306780
Subject: 3122 Cancers
PARATHYROID CARCINOMA
treatment
MGMT promoter methylation
TEMOZOLOMIDE
3121 General medicine, internal medicine and other clinical medicine
3126 Surgery, anesthesiology, intensive care, radiology
Peer reviewed: Yes
Rights: cc_by_nc_nd
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
untitled.pdf 262.5Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record